Skip to content
FDA drug shortage status

Is Lorazepam Injection in shortage?

Yes. Lorazepam Injection is on FDA’s drug shortage list (unavailable), last updated Oct 5, 2026.

In shortageFDA status
11packages listed
7unavailable

Why it’s in shortage

  • Demand increase for the drug
  • Other

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1)
    Amphastar Pharmaceuticals, Inc.In shortageAvailableUpdated Oct 5, 2026

    Maker contact: 800-423-4136

  • Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)
    Hospira, Inc., a Pfizer CompanyIn shortageLimited AvailabilityUpdated Sep 22, 2026

    Limited Supply Available. Next Delivery: July 2027; Estimated Recovery: September 2027

    Maker contact: 844-646-4398

  • Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Sep 18, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)
    Hikma Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Sep 18, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Sep 18, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)
    Hikma Pharmaceuticals USA, Inc.In shortageLimited AvailabilityUpdated Sep 18, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Sep 18, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Sep 18, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10)
    Hikma Pharmaceuticals USA, Inc.In shortageUnavailableUpdated Sep 18, 2026

    Estimated recovery: TBD

    Maker contact: 800-631-2174

  • Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Sep 15, 2026

    Next release September 2026. Check wholesalers for inventory.

    Maker contact: 888-386-1300

FDA recalls of Lorazepam

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Lorazepam Injection:

Lorazepam Injection shortage questions

Is Lorazepam Injection in shortage?

Yes. Lorazepam Injection is on FDA’s drug shortage list (unavailable), last updated Oct 5, 2026.

Why is there a Lorazepam Injection shortage?

FDA records the reason as: Demand increase for the drug; Other.

What should I do if I can’t get Lorazepam Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.